The U.S. Food and Drug Administration (FDA) has suspended Novavax's experimental combined COVID-19 and flu vaccine clinical ...

The vaccine maker said the regulator placed the hold because of a report of a “serious adverse event” of motor neuropathy in ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...

FDA places a clinical hold on Novavax's COVID-19-influenza vaccine trials due to a serious adverse event in a Phase 2 participant. Novavax's COVID-19 IND and European approval for its updated ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk ...

Shares of the vaccine maker plunged about 20% to $10.13 in early trading. Novavax said it was working with the FDA to resolve the clinical hold on the trial of its combination shot and the ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Novavax’s phase 3 trial in the US is still ongoing with 30,000 participants, but the company hope data already reported from the UK trial will be enough to convince the FDA to approve.

Related: John Jacobs is working to refocus Novavax for a new era “We are working closely with the FDA to provide the necessary information that will allow them to better understand this ...

"Fundamentally this doesn't seem to have a direct impact on Novavax's partnership with Sanofi," TD Cowen analyst Brendan Smith said. Investors will closely monitor what additional data the FDA ...

Novavax Inc. (NASDAQ:NVAX) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination ...

US FDA Pauses Novavax's Trial of Combo COVID-Flu Shot on Safety Concerns By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and ...